University of Cincinnati Medical Center is pleased to share with you Cardiovascular Insights, an educational resource with information on the cutting-edge research, clinical trials, training and innovative treatments that are advancing the field.
The standard of care paradigm has shifted in the treatment of ischemic stroke. At present, the only thrombolytic therapy approved by the U.S. Food and Drug Administration is recombinant tissue-type plasminogen activator (rt-PA), and this treatment is only administered to a small percentage of patients due to safety concerns and temporal limitations.1 Sonothrombolysis, or ultrasound-mediated
Read more →
The University of Cincinnati Heart, Lung, and Vascular Institute (HLVI) will soon initiate a three-year Mentored Research Career Development Program in vascular medicine. The goal of this initiative is to establish a comprehensive training program that will emphasize high-quality clinical and translational research in the vascular sciences, and prepare participants to serve as mentors for
Read more →This ScholarVision features Richard Becker, MD, chief of the Division of Cardiovascular Health and Disease and director, and physician-in-chief of the University of Cincinnati Heart, Lung and Vascular Institute; Joseph Broderick, MD, director of the University of Cincinnati Neuroscience Institute; and William Barrett, MD, director of the University of Cincinnati Cancer Institute. They discuss groundbreaking
Read more →Richard Becker, MD, chief of the Division of Cardiovascular Health and Disease and director, and physician-in-chief of the University of Cincinnati Heart, Lung and Vascular Institute and Michael Ritt Jaff, DO, professor of medicine at Harvard Medical School and chair of the Massachusetts General Institute for Heart, Vascular and Stroke Care discuss vascular medicine career
Read more →
After receiving a five-year, $2.4 million grant from the National Institute of Environmental Health Sciences (NIEHS), two University of Cincinnati researchers will collaborate on an investigation of gene-environment interactions during embryonic development and their consequences in adult heart disease. Alvaro Puga, PhD, of the Department of Environmental Health, and Jack Rubinstein, MD, of the Department
Read more →Richard Becker, MD, Director and Physician-in-Chief of the University of Cincinnati Heart, Lung and Vascular Institute, interviews Markus Gustche, MD, PhD, Assistant Professor in the UC College of Medicine, and Director of the Interstitial Lung Disease Program.
Read more →
